Could a single pill replace three diabetes drugs? early study begins

NCT ID NCT07548957

Not yet recruiting Knowledge-focused Sponsor: Korea United Pharm. Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests a new experimental pill called UI087, which combines three diabetes drugs into one. Researchers want to see if it is safe and how the body processes it compared to taking the three drugs separately. The study involves 44 healthy adults and is not yet testing the drug in people with diabetes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: UI087 (a combination pill for type 2 diabetes)
What this could lead to: If successful, this could lead to a simpler, single-pill treatment for type 2 diabetes, replacing the need to take three separate drugs.
What could go wrong: This is a very early (Phase 1) study in healthy volunteers, not people with diabetes. It only checks safety and drug levels, not whether it actually works for diabetes. The results may not translate to patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

H plus Yangji Hospital

Seoul, Gwanak-gu, 08779, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.